Eckert & Ziegler SE (FRA:EUZ)

Market Cap	978.55M
Revenue (ttm)	299.27M
Net Income (ttm)	36.64M
Shares Out	n/a
EPS (ttm)	0.58
PE Ratio	26.71
Forward PE	19.22
Dividend	0.17 (1.05%)
Ex-Dividend Date	Jun 19, 2025

Volume	n/a
Average Volume	437
Open	15.61
Previous Close	15.92
Day's Range	15.49 - 15.61
52-Week Range	15.49 - 69.00
Beta	n/a
RSI	21.39
Earnings Date	Nov 13, 2025

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-co...

• Industry: Industrial Inorganic Chemicals
• Founded: 2024
• Employees: 1,085
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: EUZ

Financial Performance

In 2024, Eckert & Ziegler SE's revenue was 295.85 million, an increase of 20.22% compared to the previous year's 246.09 million. Earnings were 33.28 million, an increase of 26.52%.